Uwe Pleyer – författare

Since the first edition that was published in 1998 we have seen manychanges in ophthalmology from advancements in laser surgery to new techniques in cataract surgery. With these new developing advancements symptoms, diagnosis, and treatments in ocular disease have also begun to change. Early diagnosis and management of ocular infection is essential to avoid the risk of blindness. An understanding of the related disease process and drug therapy is a key aid in achieving this. The updated Ocular InfectionSecond Edition covers the basic science of ocular infection, as well as its diagnosis and management of ocular disease, and the changes it is going through.

This handbook offers concise, evidence-based guidance for clinicians who diagnose and manage ocular disease outside tertiary centres. Written for general practitioners, optometrists, ophthalmic nurses and primary care eye professionals, it translates core science into practical steps for assessment, urgent decision making and initial therapy.The book covers common sight-threatening conditions, including glaucoma, age-related macular degeneration, diabetic and hypertensive retinopathies, uveitis, cataracts and inflammatory and immune-mediated eye disease. It provides clear, illustrated pathways for history taking, focused examination and red-flag recognition, with pragmatic advice on when to treat, when to refer and how to arrange safe follow-up.Key Practical FeaturesClinical diagnostic aids and annotated images to support decision makingManagement algorithms and treatment pearls for emergencies and routine carePractical procedures such as corneal scraping, microscopy and basic microbiology with guidance on appropriate antimicrobial therapyTherapeutic rationale covering ocular pharmacology, prescribing considerations and when to use immunomodulatory agentsPublic health and tropical perspectives on ocular infections, epidemiology and prevention of cross-infection in practiceThis book bridges the gap between specialist ophthalmology texts and everyday primary care needs, equipping clinicians with the knowledge to protect vision, reduce avoidable harm and coordinate care effectively within diverse global health settings.

This handbook offers concise, evidence-based guidance for clinicians who diagnose and manage ocular disease outside tertiary centres. Written for general practitioners, optometrists, ophthalmic nurses and primary care eye professionals, it translates core science into practical steps for assessment, urgent decision making and initial therapy.The book covers common sight-threatening conditions, including glaucoma, age-related macular degeneration, diabetic and hypertensive retinopathies, uveitis, cataracts and inflammatory and immune-mediated eye disease. It provides clear, illustrated pathways for history taking, focused examination and red-flag recognition, with pragmatic advice on when to treat, when to refer and how to arrange safe follow-up.Key Practical FeaturesClinical diagnostic aids and annotated images to support decision makingManagement algorithms and treatment pearls for emergencies and routine carePractical procedures such as corneal scraping, microscopy and basic microbiology with guidance on appropriate antimicrobial therapyTherapeutic rationale covering ocular pharmacology, prescribing considerations and when to use immunomodulatory agentsPublic health and tropical perspectives on ocular infections, epidemiology and prevention of cross-infection in practiceThis book bridges the gap between specialist ophthalmology texts and everyday primary care needs, equipping clinicians with the knowledge to protect vision, reduce avoidable harm and coordinate care effectively within diverse global health settings.

Uveitis and immunological disorders encompass a wide spectrum of potentially blinding diseases that are seen in daily practice by many ophthalmologists. In recent years enormous progress has been made understanding the principal mechanisms of inflammatory and immunological processes in ocular disorders. The purpose of this volume of Essentials in Ophthalmology is to provide the ophthalmologist with our present understanding of the pathogenesis of the most frequent immune-mediated disorders of the eye and a practical approach to these diseases.Uveitis and Immunological Disorders fits in the series of Essentials in Ophthalmology to fill the gap between textbooks and original research publications. With a broad spectrum of contributions, including diseases affecting the conjunctiva, sclera and cornea as well as intraocular inflammation, this publication will serve not only as a valuable source of up-to-date information for ophthalmologists but also be of interest to pediatricians, specialists in internal medicine and dermatologists confronted with inflammatory eye diseases.Although mainly focused on clinical aspects of inflammatory eye diseases, several contributions address aspects such as immune mechanisms and genetics of these diseases.

Te series Essentials in Ophthalmology was initi- to discuss clinically relevant and appropriate t- ated two years ago to expedite the timely trans- ics. Summaries of clinically relevant information fer of new information in vision science and have been provided throughout each chapter. evidence-based medicine into clinical practice. Each subspecialty area now has been covered We thought that this prospicient idea would be once, and the response to the frst eight volumes moved and guided by a resolute commitment in the series has been enthusiastically positive. to excellence. It is reasonable to now update our With the start of the second cycle of subspecialty readers with what has been achieved. coverage, the dissemination of practical informa- Te immediate goal was to transfer informa- tion will be continued as we learn more about tion through a high quality quarterly publication the emerging advances in various ophthalmic in which ophthalmology would be represented by subspecialties that can be applied to obtain the eight subspecialties. In this regard, each issue has best possible care of our patients. Moreover, we had a subspecialty theme and has been overseen will continue to highlight clinically relevant - by two internationally recognized volume edi- formation and maintain our commitment to - tors, who in turn have invited a bevy of experts cellence. G. K. Krieglstein R. N. Weinreb Series Editors Preface Tis second volume of Uveitis and Immunologi- tions, herpes keratitis and ocular toxoplasmosis, cal Disorders in the Essentials in Ophthalmology which still remain sight-threatening disorders.

The Essentials in Ophthalmology series represents an aged by readership acceptance of the first two series, unique updating publication on the progress in all sub- each of eight volumes. This is a success that was made specialties of ophthalmology. possible predominantly by the numerous opinion-lead- In a quarterly rhythm, eight issues are published cov- ing authors and the outstanding section editors, as well ering clinically relevant achievements in the whole field as with the constructive support of the publisher. There of ophthalmology. This timely transfer of advancements are many good reasons to continue andstill improve the for the best possible care of our eye patients has proven to dissemination of this didactic and clinically relevant be effective. The initial working hypothesis of providing information. new knowledge immediately following publication in the peer-reviewed journal and not waiting for the textbook G. K. Krieglstein appears to be highly workable. R. N. Weinreb We are now entering the third cycle of the Ess- tials in Ophthalmology series, having been encour- Series Editors Preface Our knowledge and understanding of immune-mediated the most recent research material available. The scope of diseases has increased exponentially over the past few the chapters ranges from well-recognized immune dis- years, especially in the areas of immunopathogenesis and ders such as cornea transplantation, uveitis and diabetic immunotherapeutics.

The Essentials in Ophthalmology series represents an aged by readership acceptance of the first two series, unique updating publication on the progress in all sub- each of eight volumes. This is a success that was made specialties of ophthalmology. possible predominantly by the numerous opinion-lead- In a quarterly rhythm, eight issues are published cov- ing authors and the outstanding section editors, as well ering clinically relevant achievements in the whole field as with the constructive support of the publisher. There of ophthalmology. This timely transfer of advancements are many good reasons to continue andstill improve the for the best possible care of our eye patients has proven to dissemination of this didactic and clinically relevant be effective. The initial working hypothesis of providing information. new knowledge immediately following publication in the peer-reviewed journal and not waiting for the textbook G. K. Krieglstein appears to be highly workable. R. N. Weinreb We are now entering the third cycle of the Ess- tials in Ophthalmology series, having been encour- Series Editors Preface Our knowledge and understanding of immune-mediated the most recent research material available. The scope of diseases has increased exponentially over the past few the chapters ranges from well-recognized immune dis- years, especially in the areas of immunopathogenesis and ders such as cornea transplantation, uveitis and diabetic immunotherapeutics.

Te series Essentials in Ophthalmology was initi- to discuss clinically relevant and appropriate t- ated two years ago to expedite the timely trans- ics. Summaries of clinically relevant information fer of new information in vision science and have been provided throughout each chapter. evidence-based medicine into clinical practice. Each subspecialty area now has been covered We thought that this prospicient idea would be once, and the response to the frst eight volumes moved and guided by a resolute commitment in the series has been enthusiastically positive. to excellence. It is reasonable to now update our With the start of the second cycle of subspecialty readers with what has been achieved. coverage, the dissemination of practical informa- Te immediate goal was to transfer informa- tion will be continued as we learn more about tion through a high quality quarterly publication the emerging advances in various ophthalmic in which ophthalmology would be represented by subspecialties that can be applied to obtain the eight subspecialties. In this regard, each issue has best possible care of our patients. Moreover, we had a subspecialty theme and has been overseen will continue to highlight clinically relevant - by two internationally recognized volume edi- formation and maintain our commitment to - tors, who in turn have invited a bevy of experts cellence. G. K. Krieglstein R. N. Weinreb Series Editors Preface Tis second volume of Uveitis and Immunologi- tions, herpes keratitis and ocular toxoplasmosis, cal Disorders in the Essentials in Ophthalmology which still remain sight-threatening disorders.

Indispensable for continuous education and advanced training All editors with international reputation and contributing authors with great expertise in their topic Well-structured text and design, quick and easy to read Bridges the gap between primary literature and daily practice Every 2nd year each subject is covered with timely information about new developments in the specialised field

These guidelines, compiled by a panel of clinicians and scientists with a high level of expertise, aim to provide readers with the most up-to-date and comprehensive instructions on the treatment and prevention of ocular inflammation.

These guidelines, compiled by a panel of clinicians and scientists with a high level of expertise, aim to provide readers with the most up-to-date and comprehensive instructions on the treatment and prevention of ocular inflammation. All of the recommendations are explicitly linked to supporting evidence and graded according to the strength of that evidence and the editors have made every effort to ensure that chapters are of a consistently high methodological quality. The guidelines for each treatment include dose and the frequency and mode of delivery. Significant side-effects of treatment are identified and distinguished from those of the disease in question. Suggestions are presented for the prevention both of the disease itself and of the treatment-related complications. In addition, likely future directions in treatment and prevention are identified. These guidelines will be of great practical value for all clinicians and clinical scientists with an interest in the subject.